KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $234,000 | -67.9% | 7,642 | -82.9% | 0.16% | -68.9% |
| Q2 2020 | $729,000 | -27.0% | 44,708 | -55.4% | 0.53% | -40.2% |
| Q1 2020 | $998,000 | +13.3% | 100,329 | +56.6% | 0.88% | +13.4% |
| Q4 2019 | $881,000 | +6.7% | 64,059 | +17.7% | 0.78% | -4.2% |
| Q3 2019 | $826,000 | -16.4% | 54,430 | +8.5% | 0.81% | -9.6% |
| Q2 2019 | $988,000 | +308.3% | 50,159 | +190.8% | 0.90% | +251.2% |
| Q4 2018 | $242,000 | – | 17,250 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |